AVASTIN vs LUMAKRAS

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 8, 2026·How we rate

Possible drug interaction. AVASTIN and LUMAKRAS are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	AVASTIN	LUMAKRAS
Rating	72/100	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	BEVACIZUMAB	SOTORASIB
Manufacturer	Genentech Inc	Amgen Inc
Dosage forms	Injectable	Tablet
Drug class	Vascular Endothelial Growth Factor Inhibitor	—
Boxed warning	None	None
Treats	Non-Small-Cell Lung Carcinoma, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms	Non-Small-Cell Lung Carcinoma

avastin lumakras

Rating

72/100

Pharmacy pays

—

Type

Active ingredient

BEVACIZUMAB

SOTORASIB

Manufacturer

Genentech Inc

Amgen Inc

Dosage forms

Injectable

Tablet

Drug class

Vascular Endothelial Growth Factor Inhibitor

—

Boxed warning

None

Treats

Non-Small-Cell Lung Carcinoma, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms

Non-Small-Cell Lung Carcinoma

Frequently asked questions

Which is better-rated, Avastin or Lumakras?

Avastin and Lumakras are tied at 3.6 out of 5 by our independent rating.

What is the difference between Avastin and Lumakras?

Avastin contains Bevacizumab, while Lumakras contains Sotorasib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.